Trial intelligence / Profile preview

Cefazolin Pharmacokinetics in Neonates

NCT01295606Phase 4Completed

Sponsor
UZ Leuven
Start
Feb 2011
Primary completion
Dec 2011
Modality
Reversible Covalent Inhibitors
01

Overview

A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by UZ Leuven. Started Feb 2011; status: completed.

02

Drugs

cefazolin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT01295606.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01295606.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call